Ziccum
Analyst interview in Swedish with Ziccum's CEO following the release of Q3, 2024 report
Watch Ziccum’s CEO Ann Gidner in a comprehensive interview with analyst Jonathan Furelid in Swedish on the highlights of Ziccum’s Q3 2024 report and the company’s current status.
Ziccum’s CEO, Ann Gidner, shares a number of exciting developments, including an invitation to participate in a large international consortium with key industrial and academic partners, the on-going inhaled mRNA/LNP animal studies, and the current status of the collaboration with ReCode Therapeutics.
Please watch the entire interview here: https://youtu.be/5fUJ-wSJGX8
Datum | 2024-11-01, kl 09:00 |
Källa | MFN |